219 related articles for article (PubMed ID: 24259595)
41. Adherence to lipid-lowering drug therapy among members of the Canadian Forces.
Ma J; Vaillancourt R; Bennett C
Mil Med; 2008 Jul; 173(7):666-70. PubMed ID: 18700601
[TBL] [Abstract][Full Text] [Related]
42. Complex pharmaceutical care intervention in pulmonary care: part A. The process and pharmacists' professional satisfaction.
Stuurman-Bieze AG; de Boer WO; Kokenberg ME; Hugtenburg JG; de Jong-van den Berg LT; Tromp TF
Pharm World Sci; 2005 Oct; 27(5):376-84. PubMed ID: 16341744
[TBL] [Abstract][Full Text] [Related]
43. Effects of Telephone Counseling Intervention by Pharmacists (TelCIP) on Medication Adherence; Results of a Cluster Randomized Trial.
Kooij MJ; Heerdink ER; van Dijk L; van Geffen EC; Belitser SV; Bouvy ML
Front Pharmacol; 2016; 7():269. PubMed ID: 27625605
[TBL] [Abstract][Full Text] [Related]
44. Effects of targeting disease and medication management interventions towards patients with COPD.
van Boven JF; Stuurman-Bieze AG; Hiddink EG; Postma MJ
Curr Med Res Opin; 2016; 32(2):229-39. PubMed ID: 26479017
[TBL] [Abstract][Full Text] [Related]
45. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners.
Shibley MC; Pugh CB
Ann Pharmacother; 1997 Jun; 31(6):713-9. PubMed ID: 9184710
[TBL] [Abstract][Full Text] [Related]
46. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial.
Hedegaard U; Kjeldsen LJ; Pottegård A; Bak S; Hallas J
Cerebrovasc Dis Extra; 2014; 4(3):221-34. PubMed ID: 25598772
[TBL] [Abstract][Full Text] [Related]
47. Apparent discontinuation rates in patients prescribed lipid-lowering drugs.
Simons LA; Levis G; Simons J
Med J Aust; 1996 Feb; 164(4):208-11. PubMed ID: 8604188
[TBL] [Abstract][Full Text] [Related]
48. Complex pharmaceutical care intervention in pulmonary care: part B. Patient opinion and process survey.
Stuurman-Bieze AG; Kokenberg ME; Tobi H; de Boer WO; van Doormaal JE; Jong-van den de Berg LT; Tromp TF
Pharm World Sci; 2005 Oct; 27(5):385-92. PubMed ID: 16341745
[TBL] [Abstract][Full Text] [Related]
49. Adherence and persistence associated with an appointment-based medication synchronization program.
Holdford DA; Inocencio TJ
J Am Pharm Assoc (2003); 2013; 53(6):576-83. PubMed ID: 24185429
[TBL] [Abstract][Full Text] [Related]
50. Community pharmacists' support improves antidepressant adherence in the community.
Klang SH; Ben-Amnon Y; Cohen Y; Barak Y
Int Clin Psychopharmacol; 2015 Nov; 30(6):316-9. PubMed ID: 26163876
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review.
Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
Ann Pharmacother; 2005 Feb; 39(2):319-28. PubMed ID: 15632223
[TBL] [Abstract][Full Text] [Related]
52. [IPADAM quali study. Intervention of the Pharmacist in the Issue of Self-medication: Experience of pharmacy team focus groups and patients' perceptions].
Savanovitch C; Bedhomme S; Van Lander A; Prunet-Spano C; Vennat B
Ann Pharm Fr; 2018 Sep; 76(5):399-407. PubMed ID: 29801716
[TBL] [Abstract][Full Text] [Related]
53. [Pharmaceutical intervention on the therapeutic adherence in patients with chronic renal disease].
Sánchez-Gili M; Toro-Chico P; Pérez-Encinas M; Gómez-Pedrero AM; Portolés-Pérez JM
Rev Calid Asist; 2011; 26(3):146-51. PubMed ID: 21435928
[TBL] [Abstract][Full Text] [Related]
54. Impact of community pharmacist intervention discussing patients' beliefs to improve medication adherence.
Gujral G; Winckel K; Nissen LM; Cottrell WN
Int J Clin Pharm; 2014 Oct; 36(5):1048-58. PubMed ID: 25135805
[TBL] [Abstract][Full Text] [Related]
55. Intervention fidelity for a complex behaviour change intervention in community pharmacy addressing cardiovascular disease risk.
McNamara KP; O'Reilly SL; George J; Peterson GM; Jackson SL; Duncan G; Howarth H; Dunbar JA
Health Educ Res; 2015 Dec; 30(6):897-909. PubMed ID: 26471920
[TBL] [Abstract][Full Text] [Related]
56. How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials.
Schedlbauer A; Schroeder K; Fahey T
Fam Pract; 2007 Sep; 24(4):380-7. PubMed ID: 17630270
[TBL] [Abstract][Full Text] [Related]
57. What do patients need to know? A study to assess patients' satisfaction with information about medicines.
Twigg MJ; Bhattacharya D; Clark A; Patel R; Rogers H; Whiteside H; Yaqoob M; Wright DJ
Int J Pharm Pract; 2016 Aug; 24(4):229-36. PubMed ID: 26875728
[TBL] [Abstract][Full Text] [Related]
58. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions.
Senior V; Marteau TM; Weinman J;
Cardiovasc Drugs Ther; 2004 Nov; 18(6):475-81. PubMed ID: 15770435
[TBL] [Abstract][Full Text] [Related]
59. Improving lipid control following myocardial infarction.
Ankam J; Feldman DI; Blaha MJ; Martin SS
Curr Opin Cardiol; 2014 Sep; 29(5):454-66. PubMed ID: 25046003
[TBL] [Abstract][Full Text] [Related]
60. Adherence Pattern of Lipid Lowering Drugs in a Tertiary Care Hospital.
Khatun A; Saha SK; Ajmery S; Roy P; Naushad AN; Khatun S
Mymensingh Med J; 2017 Apr; 26(2):266-271. PubMed ID: 28588160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
